Le saviez-vous ? Le nom de famille QUOIT est considéré comme rare. Il s'agit du 201 429e patronyme le plus répandu en France. Au total, on recense 34 naissances sous ce nom entre 1891 et 2000. Nombre ...

The National Drug Control Strategy is prepared biennially by the Office of National Drug Control Policy. This document provides a strategic roadmap for the Administration to continue dismantling the ...

A designer drug described as 10 times more potent than fentanyl is causing an uptick in U.S. overdoses, according to health officials in multiple states. Known as cychlorphine, the synthetic opioid is ...

President Trump's new TrumpRx online platform is a key part of his plan to help lower drug costs for consumers, with some polls showing two-thirds of Americans report high health care costs as their ...

Cartel Expert Becomes First Woman to Lead Nation’s Drug Control Policy Today, in a 52-48 vote, United States Senate confirmed Sara Carter as the 10 th Director of the White House Office of National ...

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a T-cell–mediated severe cutaneous adverse reaction characterized by rash, fever, internal organ involvement, and systemic ...

Oregon has ended its experiment with drug decriminalization. Starting Sept. 1, possession of small amounts of illicit substances are once again considered a misdemeanor crime. Earlier this year, state ...

WASHINGTON, DC—On July 30, 2024, the FBI’s Uniform Crime Reporting (UCR) Program released the special report, Human Trafficking and Drug Offenses 2013-2022, on the FBI’s Crime Data Explorer at https:/ ...

Jeremy has more than 2800 published articles on Collider to his name, and has been writing for the site since February 2022. He's an omnivore when it comes to his movie-watching diet, so will gladly ...

Daniela is a freelance writer with two years of experience covering entertainment. She is a senior writer on Collider’s freelance team and has also been published in other platforms, such as Elite ...

The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and ...